Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 190

1.

A double-blind trial of a 16-hour transdermal nicotine patch in smoking cessation.

Tønnesen P, Nørregaard J, Simonsen K, Säwe U.

N Engl J Med. 1991 Aug 1;325(5):311-5.

2.

[A double-blind trial of nicotine patches in smoking cessation].

Tønnesen P, Nørregaard J, Simonsen K, Säwe U.

Ugeskr Laeger. 1992 Jan 27;154(5):251-4. Danish.

PMID:
1736456
3.

Combined use of nicotine patch and gum in smoking cessation: a placebo-controlled clinical trial.

Kornitzer M, Boutsen M, Dramaix M, Thijs J, Gustavsson G.

Prev Med. 1995 Jan;24(1):41-7.

PMID:
7740014
4.

Effectiveness of a 16-hour transdermal nicotine patch in a medical practice setting, without intensive group counseling.

Sachs DP, Säwe U, Leischow SJ.

Arch Intern Med. 1993 Aug 23;153(16):1881-90. Erratum in: Arch Intern Med 1993 Oct 25;153(20):2321.

PMID:
8110249
5.

The transdermal nicotine patch: results of a randomised placebo-controlled trial.

Richmond RL, Harris K, de Almeida Neto A.

Med J Aust. 1994 Jul 18;161(2):130-5.

PMID:
8028537
7.

Effect of transdermal nicotine delivery as an adjunct to low-intervention smoking cessation therapy. A randomized, placebo-controlled, double-blind study.

Daughton DM, Heatley SA, Prendergast JJ, Causey D, Knowles M, Rolf CN, Cheney RA, Hatlelid K, Thompson AB, Rennard SI.

Arch Intern Med. 1991 Apr;151(4):749-52.

PMID:
2012458
9.

Safety and efficacy of the nicotine patch and gum for the treatment of adolescent tobacco addiction.

Moolchan ET, Robinson ML, Ernst M, Cadet JL, Pickworth WB, Heishman SJ, Schroeder JR.

Pediatrics. 2005 Apr;115(4):e407-14.

PMID:
15805342
10.

[Effects of transdermal nicotine as an adjunct in smoking cessation therapy. A double-blind randomized study controlled with placebo].

Daughton DM, Heatley SA, Prendergast JJ, Causey D, Knowles M, Rolf CN, Cheney RA, Hatlelid K, Thompson AB, De Blasio F, et al.

Arch Monaldi Mal Torace. 1992 Jan-Dec;47(1-6):17-29. Italian.

PMID:
1306633
11.
12.

Nicotine inhaler and nicotine patch as a combination therapy for smoking cessation: a randomized, double-blind, placebo-controlled trial.

Bohadana A, Nilsson F, Rasmussen T, Martinet Y.

Arch Intern Med. 2000 Nov 13;160(20):3128-34.

PMID:
11074742
13.

A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation.

Jorenby DE, Leischow SJ, Nides MA, Rennard SI, Johnston JA, Hughes AR, Smith SS, Muramoto ML, Daughton DM, Doan K, Fiore MC, Baker TB.

N Engl J Med. 1999 Mar 4;340(9):685-91.

14.

The nicotine patch in smoking cessation. A randomized trial with telephone counseling.

Westman EC, Levin ED, Rose JE.

Arch Intern Med. 1993 Aug 23;153(16):1917-23.

PMID:
8250653
16.

Mecamylamine combined with nicotine skin patch facilitates smoking cessation beyond nicotine patch treatment alone.

Rose JE, Behm FM, Westman EC, Levin ED, Stein RM, Ripka GV.

Clin Pharmacol Ther. 1994 Jul;56(1):86-99.

PMID:
8033499
17.

Dose effects and predictors of outcome in a randomized trial of transdermal nicotine patches in general practice.

Stapleton JA, Russell MA, Feyerabend C, Wiseman SM, Gustavsson G, Sawe U, Wiseman D.

Addiction. 1995 Jan;90(1):31-42.

PMID:
7888977
18.

Targeting heavy smokers in general practice: randomised controlled trial of transdermal nicotine patches.

Russell MA, Stapleton JA, Feyerabend C, Wiseman SM, Gustavsson G, Sawe U, Connor P.

BMJ. 1993 May 15;306(6888):1308-12.

19.

Transdermal nicotine patches with low-intensity support to aid smoking cessation in outpatients in a general hospital. A placebo-controlled trial.

Foulds J, Stapleton J, Hayward M, Russell MA, Feyerabend C, Fleming T, Costello J.

Arch Fam Med. 1993 Apr;2(4):417-23. Review.

PMID:
8130921
20.

A review of the efficacy of smoking-cessation pharmacotherapies in nonwhite populations.

Robles GI, Singh-Franco D, Ghin HL.

Clin Ther. 2008 May;30(5):800-12. doi: 10.1016/j.clinthera.2008.05.010. Review.

PMID:
18555928

Supplemental Content

Support Center